To view this page ensure that Adobe Flash Player version 11.1.0 or greater is installed.
Matti S Aapro, MD, is Dean of the Multidisciplinary Oncology Institute in Genolier, Switzerland. He coordinates the Sharing
Progress in Cancer Care (SPCC) program of the European School of Oncology (ESO) and serves the International Society
for Geriatric Oncology (SIOG) as an Executive Board member. Dr Aapro has been a member of the board of the European
Organization for Research and Treatment of Cancer (EORTC) and of the European Society of Medical Oncology (ESMO). He is
Past President of the Multinational Association for Supportive Care in Cancer (MASCC), and is now on its Board of Directors
for 2012 to 2014. He is Editor-in-Chief of Critical Reviews in Oncology/Hematology, associate editor for the geriatric section
of the Oncologist, and is founding editor of the Journal of Geriatric Oncology, and was Associate Editor for Annals of
Oncology. He directs the qualityoflife.elsevierresource.com website. He has authored more than 250 publications and his
major interests are new drug development, breast cancer, supportive care, and cancer in the elderly. Dr Aapro has received
the 2012 ASCO BJ Kennedy prize.
S pring has come and soon summer will be here. Many important meetings will be held and our knowledge will increase. New
approaches to cancer diagnosis and treatment (surgical, radio-oncological, and medical) will be presented. Progress in supportive
care will be a major focus.
This issue of Oncology & Hematology Review offers a remarkable background to compare the new data against, with updates in many
areas. New approaches to glioblastoma, triple-negative breast cancer, and neoadjuvant radiation therapy of breast cancer are discussed.
The importance of a multidisciplinary approach is exemplified in the case of metastatic colorectal cancer. The role of modern diagnostic
techniques is reported in a paper on melanoma. Two further papers discuss prostate cancer and include suggestions, such as revisiting
estrogens. In addition, immunological therapy, which is starting to spread to all cancers, is debated in a paper on renal cell carcinoma.
Finally, a paper on radiation therapy in male breast cancer discusses a rare, but important, question.
While all these developments are important, one should not forget that cancer is a disease affecting the older segment of our population.
Accordingly, the International Society of Geriatric Oncology was founded in 2000 as a multidisciplinary society which includes physicians
in the fields of oncology and geriatrics, as well as allied health professionals. It has over 1,000 members in more than 40 countries around
the world who all work in order to optimize treatment of older adults with cancer. As older patients have a very variable health status,
the need for proper integration of an oncologic and a geriatric approach has become increasingly important. Incorporating geriatric
principles into routine oncology care will serve to optimize the treatment of older cancer patients, as well as reducing their functional
impairment and its associated social and personal costs. Given the size of the problem, governmental health agencies, international
and local organizations, academic institutions, and the medical community at large will need to identify and primarily target the most
Oncology & Hematology Review is grateful to the authors, editors, and staff who have once again worked to develop such an exciting
issue. We are also grateful to all of the organizations and media partners who provide their ongoing support, and, above all, to the
Editorial Board that continues to serve this publication. n
8 © Tou ch ME dica l MEdia 2014